| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wilms Tumor | 52 | 2022 | 368 | 6.760 |
Why?
|
| Kidney Neoplasms | 50 | 2023 | 4229 | 2.720 |
Why?
|
| Nephrectomy | 30 | 2023 | 1049 | 1.810 |
Why?
|
| Neuroblastoma | 22 | 2023 | 1225 | 1.410 |
Why?
|
| Proctocolectomy, Restorative | 8 | 2013 | 189 | 1.290 |
Why?
|
| Funnel Chest | 11 | 2013 | 71 | 0.860 |
Why?
|
| Abdominal Neoplasms | 9 | 2010 | 290 | 0.850 |
Why?
|
| Mediastinal Neoplasms | 7 | 2008 | 421 | 0.820 |
Why?
|
| Adenomatous Polyposis Coli | 4 | 2010 | 224 | 0.810 |
Why?
|
| Adrenal Gland Neoplasms | 8 | 2012 | 740 | 0.760 |
Why?
|
| Anatomists | 1 | 2020 | 10 | 0.760 |
Why?
|
| Colitis, Ulcerative | 11 | 2017 | 1901 | 0.750 |
Why?
|
| Watchful Waiting | 2 | 2017 | 491 | 0.750 |
Why?
|
| Hepatoblastoma | 3 | 2015 | 87 | 0.670 |
Why?
|
| Anatomy | 1 | 2020 | 112 | 0.660 |
Why?
|
| Child | 124 | 2023 | 77478 | 0.650 |
Why?
|
| Neoplasm Staging | 38 | 2023 | 11001 | 0.630 |
Why?
|
| Child, Preschool | 96 | 2022 | 40955 | 0.580 |
Why?
|
| Colonic Pouches | 4 | 2013 | 121 | 0.580 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 31 | 2022 | 11472 | 0.550 |
Why?
|
| Neuroectodermal Tumors, Primitive | 4 | 2003 | 140 | 0.540 |
Why?
|
| Dactinomycin | 16 | 2022 | 317 | 0.530 |
Why?
|
| Neoplasm Recurrence, Local | 15 | 2017 | 9185 | 0.500 |
Why?
|
| Infant | 83 | 2022 | 35070 | 0.490 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2015 | 270 | 0.470 |
Why?
|
| Hospitals, Pediatric | 5 | 2018 | 1760 | 0.470 |
Why?
|
| Vincristine | 17 | 2022 | 1036 | 0.470 |
Why?
|
| Liver Neoplasms | 9 | 2017 | 4249 | 0.460 |
Why?
|
| Combined Modality Therapy | 32 | 2020 | 8621 | 0.430 |
Why?
|
| Thoracic Neoplasms | 5 | 2010 | 268 | 0.430 |
Why?
|
| Thyroid Nodule | 6 | 2022 | 750 | 0.420 |
Why?
|
| Bone Neoplasms | 9 | 2014 | 2522 | 0.410 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2020 | 1004 | 0.390 |
Why?
|
| Preoperative Care | 5 | 2011 | 2245 | 0.380 |
Why?
|
| Thorax | 4 | 2000 | 547 | 0.380 |
Why?
|
| Neoplasms, Multiple Primary | 4 | 2011 | 600 | 0.360 |
Why?
|
| Disease-Free Survival | 20 | 2017 | 6891 | 0.360 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 2017 | 2211 | 0.350 |
Why?
|
| Adolescent | 91 | 2022 | 85649 | 0.350 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2010 | 144 | 0.340 |
Why?
|
| Respiratory System Abnormalities | 1 | 2010 | 69 | 0.340 |
Why?
|
| Humans | 209 | 2023 | 742088 | 0.330 |
Why?
|
| Catecholamines | 2 | 2009 | 387 | 0.320 |
Why?
|
| Ribs | 4 | 2008 | 250 | 0.310 |
Why?
|
| Multicenter Studies as Topic | 1 | 2013 | 1661 | 0.310 |
Why?
|
| Students, Medical | 1 | 2020 | 1858 | 0.300 |
Why?
|
| Splenic Diseases | 2 | 1997 | 94 | 0.270 |
Why?
|
| Biopsy, Needle | 4 | 2011 | 1640 | 0.270 |
Why?
|
| Splenectomy | 3 | 2019 | 395 | 0.270 |
Why?
|
| Survival Rate | 18 | 2012 | 12773 | 0.270 |
Why?
|
| Physician's Role | 1 | 2013 | 942 | 0.260 |
Why?
|
| Male | 129 | 2022 | 349538 | 0.260 |
Why?
|
| Twins, Conjoined | 2 | 2003 | 41 | 0.260 |
Why?
|
| Neoplasm Seeding | 3 | 2013 | 87 | 0.260 |
Why?
|
| Hodgkin Disease | 6 | 2008 | 1413 | 0.260 |
Why?
|
| Lymph Node Excision | 3 | 2023 | 1248 | 0.260 |
Why?
|
| Thoracic Surgical Procedures | 3 | 2010 | 341 | 0.260 |
Why?
|
| Radiography, Thoracic | 3 | 2011 | 1265 | 0.260 |
Why?
|
| Chemotherapy, Adjuvant | 13 | 2017 | 3471 | 0.250 |
Why?
|
| Tomography, X-Ray Computed | 19 | 2014 | 20086 | 0.250 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 2005 | 83 | 0.250 |
Why?
|
| Esophagus | 2 | 2003 | 1017 | 0.250 |
Why?
|
| Doxorubicin | 16 | 2017 | 2215 | 0.240 |
Why?
|
| Thyroid Neoplasms | 6 | 2022 | 2274 | 0.240 |
Why?
|
| Female | 116 | 2022 | 379592 | 0.240 |
Why?
|
| Treatment Outcome | 37 | 2020 | 62966 | 0.230 |
Why?
|
| Crohn Disease | 4 | 2017 | 2301 | 0.230 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2005 | 772 | 0.230 |
Why?
|
| Airway Obstruction | 1 | 2008 | 663 | 0.230 |
Why?
|
| Neoadjuvant Therapy | 5 | 2017 | 2721 | 0.230 |
Why?
|
| Spleen | 4 | 1999 | 2359 | 0.230 |
Why?
|
| Loss of Heterozygosity | 5 | 2019 | 678 | 0.220 |
Why?
|
| Adrenalectomy | 3 | 2013 | 342 | 0.220 |
Why?
|
| Lung Neoplasms | 6 | 2015 | 13019 | 0.220 |
Why?
|
| Retrospective Studies | 47 | 2022 | 77098 | 0.220 |
Why?
|
| Follow-Up Studies | 29 | 2017 | 39004 | 0.220 |
Why?
|
| Cyclooxygenase 2 | 1 | 2005 | 611 | 0.210 |
Why?
|
| Kidney | 9 | 2022 | 7167 | 0.210 |
Why?
|
| Gastrointestinal Agents | 2 | 2017 | 494 | 0.210 |
Why?
|
| Radiotherapy, Adjuvant | 6 | 2017 | 1769 | 0.210 |
Why?
|
| Hepatectomy | 4 | 2010 | 550 | 0.210 |
Why?
|
| General Surgery | 2 | 2013 | 1633 | 0.210 |
Why?
|
| Thyroiditis, Autoimmune | 1 | 2022 | 101 | 0.210 |
Why?
|
| Reconstructive Surgical Procedures | 1 | 2001 | 16 | 0.200 |
Why?
|
| Wounds, Nonpenetrating | 2 | 1999 | 794 | 0.200 |
Why?
|
| Infant, Newborn | 27 | 2017 | 25575 | 0.200 |
Why?
|
| Pulmonary Blastoma | 1 | 2001 | 33 | 0.200 |
Why?
|
| Liver Function Tests | 2 | 2009 | 528 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 1 | 4 | 2019 | 657 | 0.200 |
Why?
|
| Respiratory Function Tests | 7 | 2013 | 1613 | 0.200 |
Why?
|
| Hashimoto Disease | 1 | 2022 | 93 | 0.200 |
Why?
|
| Radiography | 11 | 2013 | 7010 | 0.200 |
Why?
|
| Medical Oncology | 1 | 2013 | 2235 | 0.190 |
Why?
|
| WAGR Syndrome | 1 | 2020 | 3 | 0.190 |
Why?
|
| Renal Artery Obstruction | 1 | 2001 | 248 | 0.180 |
Why?
|
| Labetalol | 2 | 2010 | 30 | 0.180 |
Why?
|
| Splenic Vein | 1 | 1999 | 30 | 0.180 |
Why?
|
| Lymphoma | 1 | 2008 | 1873 | 0.170 |
Why?
|
| Specialties, Surgical | 2 | 2023 | 389 | 0.170 |
Why?
|
| Spherocytosis, Hereditary | 1 | 2019 | 80 | 0.170 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 3 | 2006 | 272 | 0.170 |
Why?
|
| Esophagectomy | 1 | 2003 | 447 | 0.170 |
Why?
|
| Splenic Artery | 1 | 1999 | 53 | 0.170 |
Why?
|
| Ventricular Dysfunction | 1 | 2000 | 143 | 0.170 |
Why?
|
| Aortic Coarctation | 1 | 2001 | 281 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2014 | 9941 | 0.160 |
Why?
|
| Postoperative Complications | 14 | 2017 | 15244 | 0.160 |
Why?
|
| Aorta, Abdominal | 2 | 2001 | 645 | 0.160 |
Why?
|
| Sacrum | 2 | 1997 | 289 | 0.160 |
Why?
|
| Vena Cava, Inferior | 1 | 2001 | 436 | 0.160 |
Why?
|
| Esophageal Cyst | 1 | 1997 | 13 | 0.160 |
Why?
|
| Bronchogenic Cyst | 1 | 1997 | 29 | 0.160 |
Why?
|
| Radiography, Interventional | 1 | 2005 | 1095 | 0.150 |
Why?
|
| Pediatrics | 1 | 2013 | 3462 | 0.150 |
Why?
|
| Pleural Effusion, Malignant | 1 | 1998 | 101 | 0.150 |
Why?
|
| Respiratory Insufficiency | 2 | 2011 | 1199 | 0.150 |
Why?
|
| Biopsy | 10 | 2013 | 6756 | 0.150 |
Why?
|
| Cutaneous Fistula | 1 | 1997 | 78 | 0.150 |
Why?
|
| Cyclophosphamide | 9 | 2010 | 2236 | 0.150 |
Why?
|
| Fanconi Syndrome | 1 | 2017 | 35 | 0.150 |
Why?
|
| Bacterial Vaccines | 3 | 1996 | 402 | 0.150 |
Why?
|
| Angioplasty, Balloon | 1 | 2001 | 653 | 0.150 |
Why?
|
| Anaplasia | 3 | 2022 | 16 | 0.150 |
Why?
|
| Trachea | 3 | 2010 | 1075 | 0.140 |
Why?
|
| Hamartoma Syndrome, Multiple | 2 | 2010 | 111 | 0.140 |
Why?
|
| Prognosis | 18 | 2016 | 29010 | 0.140 |
Why?
|
| Gene Fusion | 1 | 2019 | 371 | 0.140 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2010 | 4029 | 0.140 |
Why?
|
| Haemophilus Vaccines | 2 | 1995 | 69 | 0.140 |
Why?
|
| Pleural Neoplasms | 1 | 2001 | 607 | 0.140 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2001 | 933 | 0.140 |
Why?
|
| Anal Canal | 3 | 2013 | 376 | 0.140 |
Why?
|
| Prospective Studies | 22 | 2022 | 53187 | 0.140 |
Why?
|
| Vascular Surgical Procedures | 2 | 2001 | 1473 | 0.140 |
Why?
|
| Sex Distribution | 3 | 2017 | 2295 | 0.140 |
Why?
|
| Intestinal Obstruction | 4 | 2017 | 424 | 0.140 |
Why?
|
| Abdominal Injuries | 1 | 1999 | 352 | 0.140 |
Why?
|
| Arteriovenous Fistula | 1 | 1999 | 315 | 0.140 |
Why?
|
| Spina Bifida Occulta | 1 | 1995 | 31 | 0.130 |
Why?
|
| Reoperation | 7 | 2006 | 4200 | 0.130 |
Why?
|
| Abscess | 2 | 1997 | 607 | 0.130 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2019 | 325 | 0.130 |
Why?
|
| Perioperative Care | 4 | 2009 | 997 | 0.130 |
Why?
|
| Laboratories | 1 | 2019 | 461 | 0.130 |
Why?
|
| Survival Analysis | 11 | 2017 | 10248 | 0.130 |
Why?
|
| Parenteral Nutrition, Total | 3 | 1990 | 300 | 0.130 |
Why?
|
| Neoplasms | 6 | 2013 | 21596 | 0.130 |
Why?
|
| Epidermal Cyst | 1 | 1995 | 62 | 0.130 |
Why?
|
| Antibodies, Bacterial | 2 | 1992 | 1469 | 0.130 |
Why?
|
| Choledochal Cyst | 1 | 1995 | 25 | 0.130 |
Why?
|
| Neoplasm Invasiveness | 5 | 2017 | 3612 | 0.130 |
Why?
|
| Anus, Imperforate | 1 | 1995 | 66 | 0.130 |
Why?
|
| Nutrition Disorders | 2 | 1994 | 211 | 0.130 |
Why?
|
| Whole-Body Irradiation | 2 | 2006 | 449 | 0.130 |
Why?
|
| Haemophilus influenzae | 2 | 1992 | 171 | 0.130 |
Why?
|
| Precancerous Conditions | 1 | 2022 | 971 | 0.130 |
Why?
|
| Adrenergic alpha-Antagonists | 3 | 2010 | 174 | 0.120 |
Why?
|
| Liver Regeneration | 1 | 1996 | 210 | 0.120 |
Why?
|
| Common Bile Duct | 1 | 1995 | 109 | 0.120 |
Why?
|
| Pancreatin | 1 | 1994 | 9 | 0.120 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2001 | 933 | 0.120 |
Why?
|
| Lung Transplantation | 4 | 1999 | 1155 | 0.120 |
Why?
|
| Genes, Wilms Tumor | 2 | 2011 | 94 | 0.120 |
Why?
|
| Quality Assurance, Health Care | 1 | 2005 | 2211 | 0.120 |
Why?
|
| Age Factors | 8 | 2014 | 18355 | 0.120 |
Why?
|
| Remission Induction | 4 | 2008 | 2384 | 0.120 |
Why?
|
| Ileum | 1 | 2016 | 565 | 0.120 |
Why?
|
| Adenocarcinoma, Follicular | 2 | 2010 | 324 | 0.120 |
Why?
|
| Pheochromocytoma | 2 | 2007 | 337 | 0.120 |
Why?
|
| Colon | 5 | 2003 | 1773 | 0.120 |
Why?
|
| Anesthesia, General | 2 | 1999 | 1164 | 0.120 |
Why?
|
| Rectum | 2 | 2000 | 903 | 0.120 |
Why?
|
| Electrolytes | 1 | 1994 | 282 | 0.120 |
Why?
|
| Plasmapheresis | 1 | 2014 | 212 | 0.110 |
Why?
|
| Pentetic Acid | 1 | 1993 | 213 | 0.110 |
Why?
|
| Surgical Flaps | 2 | 2000 | 1634 | 0.110 |
Why?
|
| Hemoglobin SC Disease | 1 | 1993 | 22 | 0.110 |
Why?
|
| Cholelithiasis | 2 | 1993 | 411 | 0.110 |
Why?
|
| Soft Tissue Neoplasms | 4 | 2009 | 1361 | 0.110 |
Why?
|
| Rhabdomyosarcoma | 6 | 2004 | 382 | 0.110 |
Why?
|
| Water-Electrolyte Balance | 1 | 1994 | 346 | 0.110 |
Why?
|
| Laparoscopy | 3 | 2016 | 2121 | 0.110 |
Why?
|
| Age Distribution | 2 | 2017 | 2900 | 0.110 |
Why?
|
| Meglumine | 1 | 1993 | 149 | 0.110 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 1998 | 1379 | 0.110 |
Why?
|
| Laparotomy | 2 | 1995 | 474 | 0.110 |
Why?
|
| Jejunum | 1 | 1995 | 480 | 0.110 |
Why?
|
| Polysaccharides, Bacterial | 3 | 1996 | 578 | 0.110 |
Why?
|
| Head and Neck Neoplasms | 2 | 2005 | 2712 | 0.110 |
Why?
|
| Duodenum | 2 | 1995 | 483 | 0.110 |
Why?
|
| Premedication | 2 | 2002 | 257 | 0.100 |
Why?
|
| Blood Component Transfusion | 1 | 1993 | 142 | 0.100 |
Why?
|
| Cell Separation | 2 | 1996 | 1749 | 0.100 |
Why?
|
| Lipoma | 2 | 2010 | 334 | 0.100 |
Why?
|
| Tetanus Toxoid | 1 | 1992 | 193 | 0.100 |
Why?
|
| Adult | 47 | 2019 | 213712 | 0.100 |
Why?
|
| Transplantation, Autologous | 4 | 2006 | 2123 | 0.100 |
Why?
|
| Cysts | 2 | 1998 | 676 | 0.100 |
Why?
|
| Catheter Ablation | 1 | 2005 | 2746 | 0.100 |
Why?
|
| Myasthenia Gravis | 1 | 2014 | 201 | 0.100 |
Why?
|
| Lymphatic Metastasis | 3 | 2017 | 2906 | 0.100 |
Why?
|
| Cholecystectomy | 2 | 1993 | 387 | 0.100 |
Why?
|
| Feedback | 1 | 2015 | 793 | 0.100 |
Why?
|
| Purpura, Thrombocytopenic | 1 | 1991 | 43 | 0.100 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 2011 | 74 | 0.100 |
Why?
|
| Boston | 8 | 2012 | 9305 | 0.100 |
Why?
|
| Wound Healing | 4 | 1985 | 2781 | 0.100 |
Why?
|
| Immunohistochemistry | 6 | 2011 | 11363 | 0.100 |
Why?
|
| Antineoplastic Agents | 10 | 2019 | 13655 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 5 | 2013 | 6534 | 0.100 |
Why?
|
| Neoplasms, Second Primary | 3 | 2008 | 1052 | 0.100 |
Why?
|
| Surgery Department, Hospital | 1 | 1992 | 175 | 0.100 |
Why?
|
| Pokeweed Mitogens | 1 | 1990 | 38 | 0.090 |
Why?
|
| Radiotherapy | 5 | 2013 | 1525 | 0.090 |
Why?
|
| Methods | 4 | 1995 | 1128 | 0.090 |
Why?
|
| beta-Thalassemia | 1 | 1993 | 225 | 0.090 |
Why?
|
| Dopamine | 2 | 2010 | 1589 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2010 | 417 | 0.090 |
Why?
|
| Pancreaticoduodenectomy | 1 | 1994 | 503 | 0.090 |
Why?
|
| Sternum | 2 | 1988 | 175 | 0.090 |
Why?
|
| Sarcoma | 5 | 1997 | 1895 | 0.090 |
Why?
|
| Respiratory Tract Neoplasms | 1 | 2010 | 57 | 0.090 |
Why?
|
| Etoposide | 5 | 2010 | 637 | 0.090 |
Why?
|
| Medical Audit | 2 | 2005 | 467 | 0.090 |
Why?
|
| Heart Defects, Congenital | 2 | 2002 | 4566 | 0.090 |
Why?
|
| Lung Diseases, Fungal | 2 | 1992 | 122 | 0.090 |
Why?
|
| Poland Syndrome | 1 | 1989 | 14 | 0.090 |
Why?
|
| Orthopedic Procedures | 3 | 2013 | 1288 | 0.090 |
Why?
|
| Risk | 5 | 2012 | 9679 | 0.090 |
Why?
|
| Burkitt Lymphoma | 1 | 1992 | 328 | 0.090 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2014 | 657 | 0.090 |
Why?
|
| Organometallic Compounds | 1 | 1993 | 665 | 0.090 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2011 | 162 | 0.090 |
Why?
|
| Phenoxybenzamine | 1 | 2009 | 54 | 0.090 |
Why?
|
| Embolization, Therapeutic | 1 | 1999 | 1392 | 0.090 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2010 | 114 | 0.090 |
Why?
|
| Treatment Failure | 3 | 2006 | 2615 | 0.090 |
Why?
|
| Syndactyly | 1 | 1989 | 72 | 0.080 |
Why?
|
| Nurse Practitioners | 1 | 1992 | 270 | 0.080 |
Why?
|
| Neurofibroma | 1 | 1989 | 106 | 0.080 |
Why?
|
| Parenteral Nutrition | 2 | 1984 | 650 | 0.080 |
Why?
|
| Adenoma | 3 | 2011 | 2168 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 2 | 2012 | 2536 | 0.080 |
Why?
|
| Ultrasonography, Prenatal | 4 | 2002 | 1694 | 0.080 |
Why?
|
| Focal Nodular Hyperplasia | 1 | 2008 | 32 | 0.080 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2014 | 576 | 0.080 |
Why?
|
| Polyethylene Glycols | 1 | 1994 | 1181 | 0.080 |
Why?
|
| Anastomosis, Surgical | 3 | 2013 | 985 | 0.080 |
Why?
|
| Hypertension | 3 | 2009 | 8455 | 0.080 |
Why?
|
| Cohort Studies | 9 | 2017 | 40450 | 0.080 |
Why?
|
| Bone Marrow Examination | 1 | 2008 | 157 | 0.080 |
Why?
|
| Staphylococcal Infections | 1 | 1997 | 1398 | 0.080 |
Why?
|
| Keratins | 1 | 2010 | 515 | 0.080 |
Why?
|
| Vital Capacity | 1 | 2011 | 922 | 0.080 |
Why?
|
| Paracentesis | 1 | 2008 | 95 | 0.080 |
Why?
|
| Thigh | 1 | 1989 | 247 | 0.080 |
Why?
|
| Risk Assessment | 7 | 2017 | 23320 | 0.080 |
Why?
|
| Body Image | 2 | 2013 | 609 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2005 | 7873 | 0.080 |
Why?
|
| Animals, Newborn | 2 | 1999 | 2723 | 0.080 |
Why?
|
| Antihypertensive Agents | 2 | 2010 | 2043 | 0.080 |
Why?
|
| Defecation | 1 | 2009 | 188 | 0.080 |
Why?
|
| Tumor Burden | 1 | 2014 | 1905 | 0.080 |
Why?
|
| Quality of Life | 3 | 2010 | 12730 | 0.080 |
Why?
|
| Testis | 2 | 1981 | 800 | 0.080 |
Why?
|
| Lung Diseases | 3 | 2006 | 1884 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2010 | 380 | 0.080 |
Why?
|
| Ureteral Neoplasms | 1 | 2008 | 110 | 0.080 |
Why?
|
| Esophagitis | 1 | 1988 | 152 | 0.080 |
Why?
|
| Lung | 5 | 1999 | 9826 | 0.080 |
Why?
|
| Fibrosarcoma | 2 | 2002 | 348 | 0.070 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2010 | 1239 | 0.070 |
Why?
|
| Curriculum | 1 | 2020 | 3589 | 0.070 |
Why?
|
| Liposarcoma | 1 | 2010 | 333 | 0.070 |
Why?
|
| Ovary | 2 | 1981 | 981 | 0.070 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2007 | 75 | 0.070 |
Why?
|
| Time Factors | 13 | 2017 | 40054 | 0.070 |
Why?
|
| Case Management | 1 | 2008 | 286 | 0.070 |
Why?
|
| History, 21st Century | 1 | 2013 | 1533 | 0.070 |
Why?
|
| Adrenal Cortex Hormones | 4 | 2011 | 1847 | 0.070 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2007 | 692 | 0.070 |
Why?
|
| History, 20th Century | 2 | 2013 | 2739 | 0.070 |
Why?
|
| Bone Marrow Neoplasms | 1 | 2007 | 104 | 0.070 |
Why?
|
| Common Bile Duct Diseases | 1 | 1985 | 37 | 0.070 |
Why?
|
| Parotid Neoplasms | 1 | 2007 | 155 | 0.070 |
Why?
|
| Bronchi | 1 | 2010 | 840 | 0.070 |
Why?
|
| Esophageal Atresia | 1 | 1988 | 201 | 0.070 |
Why?
|
| Preanesthetic Medication | 1 | 2005 | 49 | 0.070 |
Why?
|
| Osteosarcoma | 4 | 2008 | 880 | 0.070 |
Why?
|
| Mitral Valve Prolapse | 1 | 1987 | 230 | 0.070 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 5385 | 0.070 |
Why?
|
| Incidence | 5 | 2017 | 20928 | 0.070 |
Why?
|
| Muscles | 2 | 1991 | 1617 | 0.070 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2008 | 1515 | 0.070 |
Why?
|
| Thyroidectomy | 1 | 2011 | 877 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2000 | 4933 | 0.060 |
Why?
|
| Double Outlet Right Ventricle | 1 | 2005 | 58 | 0.060 |
Why?
|
| Biological Products | 1 | 2014 | 856 | 0.060 |
Why?
|
| Recurrence | 6 | 2009 | 8333 | 0.060 |
Why?
|
| Intestinal Fistula | 2 | 2014 | 140 | 0.060 |
Why?
|
| Immunologic Factors | 1 | 2014 | 1575 | 0.060 |
Why?
|
| Pancreatitis | 3 | 2007 | 1090 | 0.060 |
Why?
|
| Enterocolitis | 1 | 1986 | 102 | 0.060 |
Why?
|
| Abdominal Cavity | 1 | 2005 | 44 | 0.060 |
Why?
|
| Bone Diseases | 1 | 2008 | 416 | 0.060 |
Why?
|
| beta Catenin | 1 | 2010 | 1058 | 0.060 |
Why?
|
| Peritoneovenous Shunt | 1 | 1984 | 9 | 0.060 |
Why?
|
| Activin Receptors, Type II | 1 | 2005 | 127 | 0.060 |
Why?
|
| Congenital Abnormalities | 2 | 2002 | 707 | 0.060 |
Why?
|
| Barrett Esophagus | 1 | 1988 | 494 | 0.060 |
Why?
|
| Diverticulum | 1 | 1985 | 136 | 0.060 |
Why?
|
| Hemodynamics | 2 | 2000 | 4197 | 0.060 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 1989 | 484 | 0.060 |
Why?
|
| Megacolon | 1 | 1983 | 10 | 0.060 |
Why?
|
| Antigens, Bacterial | 1 | 1990 | 1170 | 0.060 |
Why?
|
| Social Behavior | 1 | 2010 | 1128 | 0.060 |
Why?
|
| Intraoperative Period | 1 | 2005 | 520 | 0.060 |
Why?
|
| Syndrome | 4 | 2001 | 3248 | 0.060 |
Why?
|
| Forecasting | 1 | 2013 | 2948 | 0.060 |
Why?
|
| Neoplasm Metastasis | 3 | 2020 | 4839 | 0.060 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1996 | 3381 | 0.060 |
Why?
|
| Risk Factors | 13 | 2017 | 72145 | 0.060 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2007 | 623 | 0.060 |
Why?
|
| Pancreas | 3 | 1998 | 1684 | 0.060 |
Why?
|
| Inguinal Canal | 1 | 2003 | 69 | 0.060 |
Why?
|
| Anesthesia, Caudal | 1 | 2003 | 25 | 0.060 |
Why?
|
| Agranulocytosis | 1 | 1983 | 100 | 0.060 |
Why?
|
| Norepinephrine | 1 | 2005 | 909 | 0.050 |
Why?
|
| Iliac Artery | 1 | 1984 | 364 | 0.050 |
Why?
|
| Calcitonin | 2 | 2019 | 336 | 0.050 |
Why?
|
| Esophageal Achalasia | 1 | 2003 | 91 | 0.050 |
Why?
|
| Hernia, Inguinal | 1 | 1984 | 202 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2007 | 35342 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2000 | 5425 | 0.050 |
Why?
|
| Sex Factors | 3 | 2011 | 10392 | 0.050 |
Why?
|
| Epinephrine | 1 | 2005 | 793 | 0.050 |
Why?
|
| Carboplatin | 3 | 2010 | 799 | 0.050 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2003 | 186 | 0.050 |
Why?
|
| Esophageal Stenosis | 1 | 2003 | 194 | 0.050 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2003 | 129 | 0.050 |
Why?
|
| Sarcoma, Clear Cell | 3 | 2006 | 76 | 0.050 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 3839 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 2017 | 355 | 0.050 |
Why?
|
| Fontan Procedure | 1 | 2007 | 768 | 0.050 |
Why?
|
| Diagnosis, Differential | 8 | 2010 | 12958 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2010 | 2968 | 0.050 |
Why?
|
| Teratoma | 2 | 1996 | 387 | 0.050 |
Why?
|
| Fetofetal Transfusion | 1 | 2002 | 104 | 0.050 |
Why?
|
| Radionuclide Ventriculography | 1 | 2000 | 41 | 0.050 |
Why?
|
| Aortography | 2 | 2001 | 431 | 0.050 |
Why?
|
| Testicular Neoplasms | 3 | 1999 | 761 | 0.050 |
Why?
|
| Cause of Death | 1 | 2011 | 3571 | 0.050 |
Why?
|
| Growth Disorders | 2 | 1997 | 643 | 0.050 |
Why?
|
| Methotrexate | 3 | 1981 | 1720 | 0.050 |
Why?
|
| Intestinal Mucosa | 2 | 2009 | 3038 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2004 | 1183 | 0.050 |
Why?
|
| Health Surveys | 1 | 2010 | 4030 | 0.050 |
Why?
|
| Quality Improvement | 1 | 2015 | 3738 | 0.050 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 1986 | 3497 | 0.050 |
Why?
|
| Decision Support Techniques | 1 | 2010 | 1952 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 1990 | 3199 | 0.040 |
Why?
|
| Femoral Artery | 1 | 1984 | 843 | 0.040 |
Why?
|
| Ultrasonography | 6 | 2013 | 5978 | 0.040 |
Why?
|
| Scleroderma, Systemic | 1 | 1983 | 313 | 0.040 |
Why?
|
| Rhabdoid Tumor | 3 | 2006 | 212 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2011 | 2276 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2015 | 4681 | 0.040 |
Why?
|
| Ultrasonic Therapy | 1 | 1981 | 235 | 0.040 |
Why?
|
| Exercise Test | 2 | 2013 | 2075 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2010 | 2948 | 0.040 |
Why?
|
| Genes, myc | 3 | 1996 | 399 | 0.040 |
Why?
|
| Leukopenia | 3 | 1985 | 208 | 0.040 |
Why?
|
| Nephroma, Mesoblastic | 1 | 1999 | 25 | 0.040 |
Why?
|
| Heart Function Tests | 1 | 2000 | 330 | 0.040 |
Why?
|
| Energy Intake | 2 | 1984 | 2147 | 0.040 |
Why?
|
| Patient Selection | 1 | 2011 | 4214 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2009 | 2924 | 0.040 |
Why?
|
| Young Adult | 9 | 2019 | 56350 | 0.040 |
Why?
|
| Thyrotropin | 1 | 2022 | 850 | 0.040 |
Why?
|
| Anastomosis, Roux-en-Y | 2 | 1998 | 87 | 0.040 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2008 | 1377 | 0.040 |
Why?
|
| Ifosfamide | 2 | 2009 | 225 | 0.040 |
Why?
|
| Immunosuppressive Agents | 2 | 2013 | 4147 | 0.040 |
Why?
|
| Motor Activity | 1 | 2008 | 2714 | 0.040 |
Why?
|
| Pancreatic Pseudocyst | 1 | 1998 | 110 | 0.040 |
Why?
|
| Carbazoles | 1 | 2019 | 226 | 0.040 |
Why?
|
| Ileus | 1 | 2017 | 58 | 0.040 |
Why?
|
| Surgical Sponges | 1 | 1997 | 46 | 0.040 |
Why?
|
| Rest | 1 | 2022 | 900 | 0.040 |
Why?
|
| Surgical Stomas | 1 | 2017 | 43 | 0.040 |
Why?
|
| Aspergillosis | 2 | 1992 | 235 | 0.040 |
Why?
|
| Tensile Strength | 3 | 1985 | 334 | 0.040 |
Why?
|
| Intestine, Small | 1 | 1984 | 1243 | 0.040 |
Why?
|
| Streptococcus pneumoniae | 2 | 1996 | 712 | 0.040 |
Why?
|
| Photogrammetry | 2 | 1988 | 73 | 0.040 |
Why?
|
| Interferometry | 2 | 1988 | 98 | 0.040 |
Why?
|
| Vaccines, Conjugate | 2 | 1996 | 331 | 0.040 |
Why?
|
| Registries | 2 | 2011 | 8077 | 0.040 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2000 | 1130 | 0.040 |
Why?
|
| Testosterone | 3 | 1982 | 2401 | 0.040 |
Why?
|
| Ileostomy | 1 | 2017 | 119 | 0.040 |
Why?
|
| Anesthesia | 2 | 2005 | 1548 | 0.040 |
Why?
|
| Pain, Postoperative | 1 | 2007 | 1638 | 0.040 |
Why?
|
| Necrosis | 2 | 2010 | 1643 | 0.040 |
Why?
|
| Drug Therapy | 1 | 2020 | 497 | 0.040 |
Why?
|
| Severity of Illness Index | 4 | 2012 | 15530 | 0.040 |
Why?
|
| Kidney Transplantation | 1 | 2012 | 4246 | 0.040 |
Why?
|
| Tacrolimus | 2 | 2013 | 741 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 1990 | 4664 | 0.040 |
Why?
|
| Infarction | 1 | 1998 | 243 | 0.040 |
Why?
|
| Incidental Findings | 2 | 2013 | 688 | 0.040 |
Why?
|
| Mitotic Index | 2 | 2011 | 172 | 0.030 |
Why?
|
| Sacrococcygeal Region | 1 | 1996 | 52 | 0.030 |
Why?
|
| Maximal Expiratory Flow Rate | 1 | 1995 | 44 | 0.030 |
Why?
|
| Ileocecal Valve | 1 | 1995 | 21 | 0.030 |
Why?
|
| Ploidies | 1 | 1996 | 281 | 0.030 |
Why?
|
| Radiotherapy Dosage | 3 | 2010 | 2876 | 0.030 |
Why?
|
| Cytogenetics | 1 | 1996 | 203 | 0.030 |
Why?
|
| Acute Disease | 4 | 2011 | 7141 | 0.030 |
Why?
|
| Gastroesophageal Reflux | 1 | 2003 | 782 | 0.030 |
Why?
|
| Leukapheresis | 1 | 1996 | 131 | 0.030 |
Why?
|
| Veins | 1 | 2000 | 769 | 0.030 |
Why?
|
| Myelography | 1 | 1995 | 69 | 0.030 |
Why?
|
| Hot Temperature | 1 | 1981 | 1355 | 0.030 |
Why?
|
| Disease Progression | 3 | 2011 | 13256 | 0.030 |
Why?
|
| Random Allocation | 4 | 1996 | 2425 | 0.030 |
Why?
|
| Ossification, Heterotopic | 1 | 1998 | 239 | 0.030 |
Why?
|
| Anus Diseases | 1 | 1995 | 59 | 0.030 |
Why?
|
| Drug Administration Schedule | 2 | 2017 | 4929 | 0.030 |
Why?
|
| Regression Analysis | 3 | 2001 | 6452 | 0.030 |
Why?
|
| Heart Atria | 1 | 2001 | 1348 | 0.030 |
Why?
|
| Colectomy | 1 | 2000 | 681 | 0.030 |
Why?
|
| Diagnostic Imaging | 2 | 2022 | 3507 | 0.030 |
Why?
|
| Follicle Stimulating Hormone | 3 | 1981 | 738 | 0.030 |
Why?
|
| Thrombocytopenia | 1 | 1983 | 1171 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2005 | 2633 | 0.030 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2019 | 602 | 0.030 |
Why?
|
| Pyridostigmine Bromide | 1 | 2014 | 31 | 0.030 |
Why?
|
| Luteinizing Hormone | 3 | 1981 | 864 | 0.030 |
Why?
|
| Xylose | 1 | 1994 | 28 | 0.030 |
Why?
|
| Heart | 1 | 1988 | 4462 | 0.030 |
Why?
|
| 4-Aminobenzoic Acid | 1 | 1994 | 22 | 0.030 |
Why?
|
| Sheep | 2 | 1999 | 1437 | 0.030 |
Why?
|
| Hydroxycholecalciferols | 1 | 1994 | 44 | 0.030 |
Why?
|
| United States | 4 | 2023 | 69693 | 0.030 |
Why?
|
| Cartilage | 2 | 1988 | 818 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2005 | 2266 | 0.030 |
Why?
|
| Abdominal Muscles | 1 | 1995 | 162 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2022 | 2036 | 0.030 |
Why?
|
| Meningomyelocele | 1 | 1995 | 165 | 0.030 |
Why?
|
| Self-Examination | 1 | 2013 | 70 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 2019 | 1363 | 0.030 |
Why?
|
| Solutions | 1 | 1994 | 426 | 0.030 |
Why?
|
| Lymphography | 1 | 1994 | 201 | 0.030 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 1996 | 253 | 0.030 |
Why?
|
| Feasibility Studies | 2 | 2014 | 5062 | 0.030 |
Why?
|
| Accidents, Traffic | 1 | 1999 | 819 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2009 | 8425 | 0.030 |
Why?
|
| Vitamin A Deficiency | 1 | 1994 | 101 | 0.030 |
Why?
|
| Diseases in Twins | 1 | 1995 | 450 | 0.030 |
Why?
|
| Foreign Bodies | 1 | 1997 | 398 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 2 | 2009 | 5249 | 0.030 |
Why?
|
| Health Status Indicators | 1 | 1999 | 968 | 0.030 |
Why?
|
| Biofeedback, Psychology | 1 | 1994 | 115 | 0.030 |
Why?
|
| Mutation | 3 | 2019 | 29717 | 0.030 |
Why?
|
| Duodenal Neoplasms | 1 | 1993 | 106 | 0.030 |
Why?
|
| Therapeutic Irrigation | 1 | 1994 | 300 | 0.030 |
Why?
|
| Lidocaine | 1 | 1996 | 542 | 0.030 |
Why?
|
| Immunoglobulin G | 4 | 2008 | 4554 | 0.030 |
Why?
|
| Hospital Bed Capacity, 300 to 499 | 1 | 1992 | 60 | 0.030 |
Why?
|
| Lung Abscess | 1 | 1992 | 42 | 0.030 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 1995 | 404 | 0.030 |
Why?
|
| Hamartoma | 1 | 1994 | 234 | 0.030 |
Why?
|
| Spinal Cord Neoplasms | 1 | 1995 | 281 | 0.030 |
Why?
|
| Intestinal Absorption | 1 | 1994 | 420 | 0.030 |
Why?
|
| Alkylating Agents | 1 | 1993 | 139 | 0.030 |
Why?
|
| Bronchial Fistula | 1 | 1992 | 85 | 0.030 |
Why?
|
| Thyroid Gland | 2 | 2013 | 1172 | 0.030 |
Why?
|
| Body Weight | 3 | 1996 | 4664 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 1995 | 880 | 0.030 |
Why?
|
| Intestinal Perforation | 1 | 2014 | 252 | 0.030 |
Why?
|
| Second-Look Surgery | 1 | 2011 | 29 | 0.030 |
Why?
|
| Gene Expression | 1 | 2005 | 7790 | 0.030 |
Why?
|
| Gastric Emptying | 1 | 1994 | 233 | 0.030 |
Why?
|
| Respiratory Tract Diseases | 1 | 1997 | 722 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 1995 | 931 | 0.030 |
Why?
|
| Pleural Diseases | 1 | 1992 | 139 | 0.030 |
Why?
|
| Paraganglioma | 1 | 1993 | 143 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 1995 | 1095 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 1995 | 766 | 0.030 |
Why?
|
| Fetal Diseases | 2 | 1995 | 903 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2013 | 648 | 0.020 |
Why?
|
| Multiple Endocrine Neoplasia Type 2a | 1 | 2011 | 44 | 0.020 |
Why?
|
| Piperidines | 1 | 2019 | 1602 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2016 | 1093 | 0.020 |
Why?
|
| Papilloma | 1 | 1992 | 148 | 0.020 |
Why?
|
| Granulosa Cell Tumor | 1 | 1992 | 70 | 0.020 |
Why?
|
| Predictive Value of Tests | 3 | 2014 | 15056 | 0.020 |
Why?
|
| Pneumococcal Infections | 1 | 1996 | 496 | 0.020 |
Why?
|
| Thoracotomy | 1 | 1993 | 363 | 0.020 |
Why?
|
| Cryptorchidism | 1 | 1992 | 123 | 0.020 |
Why?
|
| Rats, Inbred F344 | 2 | 1982 | 862 | 0.020 |
Why?
|
| Goiter | 1 | 2011 | 86 | 0.020 |
Why?
|
| Odds Ratio | 2 | 2016 | 9846 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 1991 | 133 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 6171 | 0.020 |
Why?
|
| Pressure | 1 | 1994 | 1203 | 0.020 |
Why?
|
| Diphtheria Toxoid | 1 | 1990 | 28 | 0.020 |
Why?
|
| Fluorouracil | 2 | 2008 | 1615 | 0.020 |
Why?
|
| Portoenterostomy, Hepatic | 1 | 1990 | 16 | 0.020 |
Why?
|
| Mesalamine | 1 | 2011 | 136 | 0.020 |
Why?
|
| Menstruation | 2 | 1981 | 299 | 0.020 |
Why?
|
| Collagen | 3 | 1985 | 2684 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 1993 | 836 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1992 | 1676 | 0.020 |
Why?
|
| Neisseria meningitidis | 1 | 1990 | 109 | 0.020 |
Why?
|
| Genetic Markers | 1 | 1996 | 2633 | 0.020 |
Why?
|
| Cystadenoma, Mucinous | 1 | 2009 | 59 | 0.020 |
Why?
|
| Suture Techniques | 1 | 1995 | 797 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 1991 | 326 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 1996 | 1269 | 0.020 |
Why?
|
| Hypocalcemia | 1 | 2011 | 191 | 0.020 |
Why?
|
| Femoral Nerve | 1 | 1989 | 39 | 0.020 |
Why?
|
| Biliary Atresia | 1 | 1990 | 72 | 0.020 |
Why?
|
| Intention to Treat Analysis | 1 | 2010 | 425 | 0.020 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 1995 | 859 | 0.020 |
Why?
|
| Catheterization, Central Venous | 1 | 2014 | 514 | 0.020 |
Why?
|
| Mesna | 1 | 2008 | 66 | 0.020 |
Why?
|
| Nutritional Support | 1 | 2011 | 168 | 0.020 |
Why?
|
| Drug Therapy, Combination | 3 | 2007 | 6483 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2017 | 1927 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2014 | 12242 | 0.020 |
Why?
|
| Cranial Irradiation | 1 | 1992 | 401 | 0.020 |
Why?
|
| WT1 Proteins | 1 | 2009 | 178 | 0.020 |
Why?
|
| Hyperthyroidism | 1 | 2011 | 293 | 0.020 |
Why?
|
| Anesthesia, Local | 1 | 1991 | 268 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 1992 | 992 | 0.020 |
Why?
|
| Medical Illustration | 1 | 1989 | 133 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2013 | 1184 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 1991 | 625 | 0.020 |
Why?
|
| Osteochondroma | 1 | 2008 | 47 | 0.020 |
Why?
|
| Sweating | 1 | 2009 | 123 | 0.020 |
Why?
|
| Ampulla of Vater | 1 | 1989 | 141 | 0.020 |
Why?
|
| Hand Deformities, Congenital | 1 | 1989 | 145 | 0.020 |
Why?
|
| Platelet Count | 1 | 1991 | 780 | 0.020 |
Why?
|
| Sarcoma, Synovial | 1 | 2009 | 164 | 0.020 |
Why?
|
| Dilatation, Pathologic | 2 | 1995 | 520 | 0.020 |
Why?
|
| Bone Cysts, Aneurysmal | 1 | 2008 | 73 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 1992 | 2027 | 0.020 |
Why?
|
| Endoscopy, Digestive System | 1 | 2011 | 345 | 0.020 |
Why?
|
| Spirometry | 1 | 2011 | 862 | 0.020 |
Why?
|
| Drug Combinations | 1 | 1993 | 1961 | 0.020 |
Why?
|
| Leiomyoma | 1 | 1993 | 728 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 1998 | 5975 | 0.020 |
Why?
|
| Urogenital Neoplasms | 1 | 1989 | 135 | 0.020 |
Why?
|
| Physical Examination | 1 | 2013 | 1239 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 1992 | 1538 | 0.020 |
Why?
|
| Brachytherapy | 1 | 1995 | 1246 | 0.020 |
Why?
|
| Fetus | 1 | 1995 | 1879 | 0.020 |
Why?
|
| Cholestasis | 1 | 1990 | 378 | 0.020 |
Why?
|
| Hemoptysis | 1 | 1988 | 155 | 0.020 |
Why?
|
| Bone Nails | 1 | 1988 | 219 | 0.020 |
Why?
|
| Melphalan | 1 | 2008 | 431 | 0.020 |
Why?
|
| Spinal Cord | 1 | 1995 | 1807 | 0.020 |
Why?
|
| Quality Control | 1 | 2009 | 841 | 0.020 |
Why?
|
| Bile Duct Neoplasms | 1 | 1992 | 567 | 0.020 |
Why?
|
| Tachycardia | 1 | 2009 | 620 | 0.020 |
Why?
|
| Workload | 1 | 1992 | 849 | 0.020 |
Why?
|
| Penicillium | 1 | 1985 | 22 | 0.020 |
Why?
|
| Prednisone | 1 | 1991 | 1567 | 0.020 |
Why?
|
| Pericardial Effusion | 1 | 1988 | 246 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2017 | 3465 | 0.020 |
Why?
|
| Chondrosarcoma | 1 | 2008 | 309 | 0.020 |
Why?
|
| Abdomen | 1 | 2012 | 1107 | 0.020 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2008 | 647 | 0.020 |
Why?
|
| Nitrogen | 2 | 1984 | 343 | 0.020 |
Why?
|
| Doxazosin | 1 | 2005 | 19 | 0.020 |
Why?
|
| Intraoperative Complications | 2 | 2001 | 1188 | 0.020 |
Why?
|
| Carcinoma, Papillary | 1 | 2011 | 781 | 0.020 |
Why?
|
| Analysis of Variance | 3 | 2004 | 6365 | 0.020 |
Why?
|
| Liver | 4 | 1996 | 7470 | 0.020 |
Why?
|
| Pregnancy | 4 | 2002 | 29087 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2008 | 694 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2010 | 1849 | 0.020 |
Why?
|
| Antibody Formation | 1 | 1990 | 1402 | 0.020 |
Why?
|
| Neoplasm, Residual | 1 | 2010 | 974 | 0.020 |
Why?
|
| Family Health | 1 | 2010 | 1282 | 0.020 |
Why?
|
| Intestines | 1 | 2014 | 1923 | 0.020 |
Why?
|
| Middle Aged | 9 | 2006 | 213127 | 0.020 |
Why?
|
| Diastole | 1 | 2007 | 791 | 0.020 |
Why?
|
| Logistic Models | 2 | 2010 | 13403 | 0.020 |
Why?
|
| Bacterial Capsules | 2 | 1996 | 251 | 0.020 |
Why?
|
| Pneumothorax | 1 | 1988 | 379 | 0.020 |
Why?
|
| Morbidity | 1 | 2010 | 1767 | 0.020 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2008 | 546 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 1996 | 3164 | 0.020 |
Why?
|
| Thromboembolism | 1 | 2011 | 983 | 0.020 |
Why?
|
| Vitamin D Deficiency | 1 | 1994 | 1331 | 0.020 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 1984 | 65 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2010 | 14720 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 1991 | 1811 | 0.010 |
Why?
|
| Estradiol | 2 | 1981 | 2021 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2007 | 784 | 0.010 |
Why?
|
| Stomach Neoplasms | 1 | 1993 | 1327 | 0.010 |
Why?
|
| Peritoneal Neoplasms | 1 | 2010 | 663 | 0.010 |
Why?
|
| Carcinoma, Renal Cell | 1 | 1999 | 3123 | 0.010 |
Why?
|
| Exercise Tolerance | 1 | 2008 | 770 | 0.010 |
Why?
|
| Program Evaluation | 1 | 1992 | 2485 | 0.010 |
Why?
|
| Neuroendocrine Tumors | 1 | 2009 | 594 | 0.010 |
Why?
|
| Heparin | 1 | 2011 | 1636 | 0.010 |
Why?
|
| Anemia | 2 | 1985 | 1499 | 0.010 |
Why?
|
| Probability | 1 | 2008 | 2502 | 0.010 |
Why?
|
| Candidiasis | 1 | 1985 | 365 | 0.010 |
Why?
|
| Length of Stay | 1 | 2016 | 6294 | 0.010 |
Why?
|
| Myeloablative Agonists | 1 | 2003 | 218 | 0.010 |
Why?
|
| Malabsorption Syndromes | 1 | 1983 | 135 | 0.010 |
Why?
|
| Osteotomy | 1 | 1988 | 823 | 0.010 |
Why?
|
| Scoliosis | 1 | 1989 | 719 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 17400 | 0.010 |
Why?
|
| Cisplatin | 1 | 2008 | 1637 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2009 | 2713 | 0.010 |
Why?
|
| Castration | 1 | 1982 | 158 | 0.010 |
Why?
|
| Massachusetts | 1 | 2015 | 8662 | 0.010 |
Why?
|
| Image Enhancement | 1 | 1993 | 2921 | 0.010 |
Why?
|
| Muscular Diseases | 1 | 1987 | 557 | 0.010 |
Why?
|
| Pedigree | 1 | 2010 | 4646 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 2010 | 1786 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2012 | 2749 | 0.010 |
Why?
|
| Blood Pressure | 2 | 2010 | 8541 | 0.010 |
Why?
|
| Procollagen | 1 | 1982 | 185 | 0.010 |
Why?
|
| Thoracic Surgery | 1 | 1988 | 713 | 0.010 |
Why?
|
| Abnormalities, Multiple | 1 | 1989 | 1416 | 0.010 |
Why?
|
| Hernia, Umbilical | 1 | 2003 | 96 | 0.010 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2004 | 430 | 0.010 |
Why?
|
| Liver Diseases | 1 | 1990 | 1252 | 0.010 |
Why?
|
| Oligospermia | 1 | 1981 | 59 | 0.010 |
Why?
|
| Graft Survival | 1 | 2012 | 3733 | 0.010 |
Why?
|
| Polyvinyls | 1 | 1982 | 157 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 24913 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 57683 | 0.010 |
Why?
|
| Thiotepa | 1 | 1981 | 66 | 0.010 |
Why?
|
| Sarcoma, Experimental | 1 | 1981 | 128 | 0.010 |
Why?
|
| Mechlorethamine | 1 | 1981 | 136 | 0.010 |
Why?
|
| Drainage | 1 | 1987 | 1140 | 0.010 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 1984 | 321 | 0.010 |
Why?
|
| Spine | 1 | 1988 | 1143 | 0.010 |
Why?
|
| Skin Physiological Phenomena | 1 | 1981 | 180 | 0.010 |
Why?
|
| Neutropenia | 1 | 1986 | 891 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2008 | 2763 | 0.010 |
Why?
|
| Heart Failure | 1 | 2004 | 10856 | 0.010 |
Why?
|
| Sperm Count | 1 | 1981 | 216 | 0.010 |
Why?
|
| Breast | 1 | 1989 | 1958 | 0.010 |
Why?
|
| Phenotype | 1 | 2017 | 16331 | 0.010 |
Why?
|
| Radiography, Abdominal | 1 | 1983 | 537 | 0.010 |
Why?
|
| Aortic Aneurysm | 1 | 1985 | 643 | 0.010 |
Why?
|
| Neurosurgical Procedures | 1 | 2011 | 2002 | 0.010 |
Why?
|
| Rats | 4 | 1990 | 24265 | 0.010 |
Why?
|
| Blood Component Removal | 1 | 2000 | 125 | 0.010 |
Why?
|
| Azathioprine | 1 | 1981 | 355 | 0.010 |
Why?
|
| Blood Proteins | 1 | 1984 | 1122 | 0.010 |
Why?
|
| Animals | 8 | 1999 | 168561 | 0.010 |
Why?
|
| Urologic Surgical Procedures, Male | 1 | 1999 | 75 | 0.010 |
Why?
|
| Minnesota | 1 | 1999 | 343 | 0.010 |
Why?
|
| Rectal Diseases | 1 | 2000 | 142 | 0.010 |
Why?
|
| Pneumonectomy | 1 | 1985 | 1093 | 0.010 |
Why?
|
| Epidemiologic Methods | 1 | 2004 | 1364 | 0.010 |
Why?
|
| Hospitals, University | 1 | 2001 | 571 | 0.010 |
Why?
|
| Atrophy | 1 | 1983 | 1576 | 0.010 |
Why?
|
| Frozen Sections | 1 | 1999 | 155 | 0.010 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2009 | 1631 | 0.010 |
Why?
|
| Liver Transplantation | 1 | 1990 | 2117 | 0.010 |
Why?
|
| Parents | 1 | 1992 | 3387 | 0.010 |
Why?
|
| Colonic Diseases | 1 | 2000 | 202 | 0.010 |
Why?
|
| Body Temperature | 1 | 1981 | 776 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 1996 | 3862 | 0.010 |
Why?
|
| Algorithms | 1 | 1999 | 13853 | 0.010 |
Why?
|
| Hospitals, Community | 1 | 2001 | 348 | 0.010 |
Why?
|
| Fever | 1 | 1986 | 1612 | 0.010 |
Why?
|
| Amino Acids | 1 | 1984 | 1727 | 0.010 |
Why?
|
| Amenorrhea | 1 | 1981 | 485 | 0.010 |
Why?
|
| Diploidy | 1 | 1998 | 138 | 0.010 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2004 | 1144 | 0.010 |
Why?
|
| Gene Amplification | 2 | 1993 | 1062 | 0.010 |
Why?
|
| Gastritis | 1 | 1998 | 191 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 12344 | 0.010 |
Why?
|
| Diarrhea | 1 | 1983 | 1343 | 0.010 |
Why?
|
| Prevalence | 1 | 2013 | 15194 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2008 | 3391 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 1999 | 675 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1991 | 9144 | 0.010 |
Why?
|
| Palliative Care | 1 | 2011 | 3478 | 0.010 |
Why?
|
| Karyotyping | 1 | 1998 | 1243 | 0.010 |
Why?
|
| Aged | 2 | 2006 | 162944 | 0.010 |
Why?
|
| Surgical Procedures, Operative | 1 | 2007 | 1873 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2011 | 4595 | 0.010 |
Why?
|
| Serotyping | 1 | 1996 | 338 | 0.010 |
Why?
|
| Ileal Diseases | 1 | 1995 | 74 | 0.010 |
Why?
|
| Meningococcal Vaccines | 1 | 1995 | 95 | 0.010 |
Why?
|
| Pleural Effusion | 1 | 1998 | 338 | 0.010 |
Why?
|
| Internet | 1 | 2007 | 3062 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 1975 | 329 | 0.010 |
Why?
|
| Echocardiography | 1 | 1987 | 5097 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2005 | 4328 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 2007 | 3656 | 0.010 |
Why?
|
| Germinoma | 1 | 1995 | 133 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 7901 | 0.010 |
Why?
|
| Aneuploidy | 1 | 1998 | 530 | 0.010 |
Why?
|
| Organ Size | 1 | 1999 | 2253 | 0.010 |
Why?
|
| Myenteric Plexus | 1 | 1993 | 39 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2009 | 13921 | 0.010 |
Why?
|
| Ganglia, Autonomic | 1 | 1993 | 42 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2009 | 9410 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2004 | 2842 | 0.010 |
Why?
|
| Antibodies, Neoplasm | 1 | 1975 | 286 | 0.010 |
Why?
|
| Ectoderm | 1 | 1993 | 137 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1998 | 1400 | 0.010 |
Why?
|
| Hernia, Ventral | 1 | 1995 | 155 | 0.010 |
Why?
|
| Inflammation | 1 | 1992 | 10578 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 7153 | 0.010 |
Why?
|
| Internship and Residency | 1 | 1992 | 5774 | 0.010 |
Why?
|
| Pneumococcal Vaccines | 1 | 1996 | 390 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 9274 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1995 | 1030 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 12071 | 0.010 |
Why?
|
| Immunization | 1 | 1996 | 1255 | 0.010 |
Why?
|
| Gallbladder | 1 | 1992 | 301 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 1999 | 4771 | 0.010 |
Why?
|
| Macrophages | 1 | 1985 | 5655 | 0.010 |
Why?
|
| Deficiency Diseases | 1 | 1990 | 72 | 0.010 |
Why?
|
| Intestinal Diseases | 1 | 1995 | 531 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1993 | 2645 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 1982 | 2400 | 0.010 |
Why?
|
| Trisomy | 1 | 1991 | 266 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1990 | 2191 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1981 | 10943 | 0.000 |
Why?
|
| Pilot Projects | 1 | 2001 | 8297 | 0.000 |
Why?
|
| Comorbidity | 1 | 2002 | 10372 | 0.000 |
Why?
|
| Tars | 1 | 1967 | 20 | 0.000 |
Why?
|
| Marfan Syndrome | 1 | 1989 | 240 | 0.000 |
Why?
|
| Plants, Toxic | 1 | 1967 | 76 | 0.000 |
Why?
|
| Pancreatic Ducts | 1 | 1989 | 328 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1975 | 2614 | 0.000 |
Why?
|
| Tissue and Organ Procurement | 1 | 1994 | 890 | 0.000 |
Why?
|
| Graft Rejection | 1 | 1999 | 4393 | 0.000 |
Why?
|
| Ilium | 1 | 1987 | 155 | 0.000 |
Why?
|
| Proteins | 1 | 1981 | 6096 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 2003 | 11470 | 0.000 |
Why?
|
| Ultrasonics | 1 | 1987 | 212 | 0.000 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1993 | 987 | 0.000 |
Why?
|
| Tissue Donors | 1 | 1994 | 2205 | 0.000 |
Why?
|
| Pregnancy Outcome | 1 | 1995 | 2795 | 0.000 |
Why?
|
| Cardiac Surgical Procedures | 1 | 1999 | 3526 | 0.000 |
Why?
|
| Genital Neoplasms, Female | 1 | 1989 | 516 | 0.000 |
Why?
|
| Nicotine | 1 | 1967 | 677 | 0.000 |
Why?
|
| Methylhistidines | 1 | 1981 | 37 | 0.000 |
Why?
|
| Glioblastoma | 1 | 1975 | 3456 | 0.000 |
Why?
|
| Wounds, Gunshot | 1 | 1985 | 562 | 0.000 |
Why?
|
| Models, Biological | 1 | 1993 | 9581 | 0.000 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1989 | 2229 | 0.000 |
Why?
|
| Brain Neoplasms | 1 | 1995 | 8829 | 0.000 |
Why?
|
| Protein Biosynthesis | 1 | 1981 | 2126 | 0.000 |
Why?
|
| Neoplasms, Experimental | 1 | 1975 | 1274 | 0.000 |
Why?
|
| Chemistry | 1 | 1967 | 352 | 0.000 |
Why?
|
| Chemical Phenomena | 1 | 1967 | 517 | 0.000 |
Why?
|
| Prostatic Neoplasms | 1 | 1989 | 11039 | 0.000 |
Why?
|
| Cell Line | 1 | 1975 | 15994 | 0.000 |
Why?
|
| Smoking | 1 | 1967 | 8969 | 0.000 |
Why?
|